Zhou L, Zhang W, Hu X, Wang D, Tang D
Clin Med Insights Oncol. 2024; 18:11795549241287058.
PMID: 39450056
PMC: 11500237.
DOI: 10.1177/11795549241287058.
Ni X, Lu C, Xu G, Ma J
Acta Pharmacol Sin. 2024; 45(8):1533-1555.
PMID: 38622288
PMC: 11272797.
DOI: 10.1038/s41401-024-01264-1.
Jin X, Zhang Y, Wang D, Zhang X, Li Y, Wang D
iScience. 2024; 27(4):109315.
PMID: 38487547
PMC: 10937114.
DOI: 10.1016/j.isci.2024.109315.
Mazumder S, Higgins P, Samarakoon R
Cancers (Basel). 2023; 15(4).
PMID: 36831657
PMC: 9953937.
DOI: 10.3390/cancers15041316.
Shao L, Liang L, Fang Q, Wang J
Heliyon. 2022; 8(10):e10832.
PMID: 36217480
PMC: 9547242.
DOI: 10.1016/j.heliyon.2022.e10832.
Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
Zhu Y, Li X, Wang L, Hong X, Yang J
Front Endocrinol (Lausanne). 2022; 13:988295.
PMID: 36046791
PMC: 9421293.
DOI: 10.3389/fendo.2022.988295.
MicroRNAs as Regulators of Cancer Cell Energy Metabolism.
Muthukumaran N, Velusamy P, Akino Mercy C, Langford D, Natarajaseenivasan K, Shanmughapriya S
J Pers Med. 2022; 12(8).
PMID: 36013278
PMC: 9410355.
DOI: 10.3390/jpm12081329.
Metabolic Reprogramming in Gastric Cancer: Trojan Horse Effect.
Bin Y, Hu H, Tian F, Wen Z, Yang M, Wu B
Front Oncol. 2022; 11:745209.
PMID: 35096565
PMC: 8790521.
DOI: 10.3389/fonc.2021.745209.
Cancer Cells' Metabolism Dynamics in Renal Cell Carcinoma Patients' Outcome: Influence of GLUT-1-Related hsa-miR-144 and hsa-miR-186.
Morais M, Dias F, Nogueira I, Leao A, Goncalves N, Araujo L
Cancers (Basel). 2021; 13(7).
PMID: 33917405
PMC: 8038683.
DOI: 10.3390/cancers13071733.
HEMGN and SLC2A1 might be potential diagnostic biomarkers of steroid-induced osteonecrosis of femoral head: study based on WGCNA and DEGs screening.
Wu Z, Wen Y, Fan G, He H, Zhou S, Chen L
BMC Musculoskelet Disord. 2021; 22(1):85.
PMID: 33451334
PMC: 7811219.
DOI: 10.1186/s12891-021-03958-7.
Roles of microRNA-186 and vascular endothelial growth factor in hepatocellular carcinoma complicated with portal vein tumor thrombus.
Yuan W, Li F
Exp Ther Med. 2020; 20(4):3860-3867.
PMID: 32855736
PMC: 7444326.
DOI: 10.3892/etm.2020.9092.
Impaired Replication Timing Promotes Tissue-Specific Expression of Common Fragile Sites.
Maccaroni K, Balzano E, Mirimao F, Giunta S, Pelliccia F
Genes (Basel). 2020; 11(3).
PMID: 32204553
PMC: 7140878.
DOI: 10.3390/genes11030326.
Deep RNA-Seq reveals miRNome differences in mammary tissue of lactating Holstein and Montbéliarde cows.
Billa P, Faulconnier Y, Ye T, Chervet M, Le Provost F, Pires J
BMC Genomics. 2019; 20(1):621.
PMID: 31362707
PMC: 6668132.
DOI: 10.1186/s12864-019-5987-4.
Overexpression of hsa-miR-186 induces chromosomal instability in arsenic-exposed human keratinocytes.
Wu J, Ferragut Cardoso A, States V, Al-Eryani L, Doll M, Wise S
Toxicol Appl Pharmacol. 2019; 378:114614.
PMID: 31176655
PMC: 6746570.
DOI: 10.1016/j.taap.2019.114614.
Hypoxia- and MicroRNA-Induced Metabolic Reprogramming of Tumor-Initiating Cells.
Ullmann P, Nurmik M, Begaj R, Haan S, Letellier E
Cells. 2019; 8(6).
PMID: 31159361
PMC: 6627778.
DOI: 10.3390/cells8060528.
The miR-186-3p/EREG axis orchestrates tamoxifen resistance and aerobic glycolysis in breast cancer cells.
He M, Jin Q, Chen C, Liu Y, Ye X, Jiang Y
Oncogene. 2019; 38(28):5551-5565.
PMID: 30967627
DOI: 10.1038/s41388-019-0817-3.
Metabolic Reprogramming of Cancer Associated Fibroblasts: The Slavery of Stromal Fibroblasts.
Avagliano A, Granato G, Ruocco M, Romano V, Belviso I, Carfora A
Biomed Res Int. 2018; 2018:6075403.
PMID: 29967776
PMC: 6008683.
DOI: 10.1155/2018/6075403.
Inhibition of miR-186-5p contributes to high glucose-induced injury in AC16 cardiomyocytes.
Jiang J, Mo H, Liu C, Wu B, Wu Z, Li X
Exp Ther Med. 2018; 15(1):627-632.
PMID: 29399065
PMC: 5772612.
DOI: 10.3892/etm.2017.5445.
MicroRNA-186 regulates the invasion and metastasis of bladder cancer via vascular endothelial growth factor C.
He X, Ping J, Wen D
Exp Ther Med. 2017; 14(4):3253-3258.
PMID: 28966690
PMC: 5613196.
DOI: 10.3892/etm.2017.4908.
MicroRNA-186 affects the proliferation of tumor cells via yes-associated protein 1 in the occurrence and development of pancreatic cancer.
Niu Q, Li X, Xia D, Jiang Y, Tian Z, Bian C
Exp Ther Med. 2017; 14(3):2094-2100.
PMID: 28962129
PMC: 5609192.
DOI: 10.3892/etm.2017.4770.